Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Chemicals Specialty Chemicals
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration... see more

Recent & Breaking News (NYSE:DNA)

Evo Foods and Ginkgo Bioworks Announce Partnership to Develop Animal-Free Egg Products

PR Newswire May 11, 2022

Ginkgo Bioworks Announces Date of First Quarter 2022 Results Presentation

PR Newswire May 9, 2022

Ginkgo Bioworks to Expand Platform Capabilities in Agricultural Biologicals and Launch Flagship Partnership with Bayer

PR Newswire April 22, 2022

Light Bio Partners with Ginkgo Bioworks to Optimize the Brightness of Glowing Plants through Bioluminescence Engineering

PR Newswire April 14, 2022

FREDsense and Ginkgo Bioworks Announce Partnership to Develop Water Quality Biosensors

PR Newswire April 13, 2022

Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics

PR Newswire April 12, 2022

Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology

PR Newswire April 11, 2022

Twist Bioscience and Ginkgo Bioworks Sign New Collaboration

Business Wire April 5, 2022

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

PR Newswire April 4, 2022

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results

PR Newswire March 28, 2022

CDC, Concentric by Ginkgo and XpresCheck® Publish Results of CDC COVID-19 Air Travel Biosecurity Program at International Airports

PR Newswire March 23, 2022

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2021 Results Presentation and Date for Annual Meeting of Shareholders

PR Newswire March 17, 2022

Ginkgo Bioworks Announces Participation in Jefferies Virtual Synthetic Biology Week

PR Newswire March 15, 2022

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform

PR Newswire March 14, 2022

Phytolon and Ginkgo Bioworks Collaborate to Take Biological Production of Vibrant Food Colors to the Next Level

PR Newswire February 28, 2022

Ginkgo Bioworks Announces Participation in Upcoming Conferences

PR Newswire February 24, 2022

Cronos Group Reports 2021 Third Quarter Results

GlobeNewswire February 18, 2022

Ginkgo Bioworks Announces Participation in Upcoming Conferences

PR Newswire February 8, 2022

Did You Acquire (DNA) Before May 11, 2021? Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel

Newsfile February 1, 2022

Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC

PR Newswire January 19, 2022